PRNewsWire - Health

Unravelling the infection enigma: Jean-Laurent Casanova's pioneering genetic discoveries earn him the 2025 Novo Nordisk Prize
Vantage Foundation Brings Hope and Support to Patients at National Burn Hospital, Hanoi
Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
The European Medicines Agency (EMA) Has Approved an Additional Subcutaneous Administration Option for TAKHZYRO® (lanadelumab) for Patients Aged 12 Years and Above with Recurrent Attacks of Hereditary Angioedema (HAE)